CAS: 339186-68-4 - Matuzumab
Formula:Unspecified
- Sinonimi:
- Emd 62000
- Emd 7200
- Emd 72000
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal 425 γ1-chain), disulfide with human-mouse monoclonal 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (humanized MAb 425 γ1-chain), disulfide with humanized MAb 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor)(humanized MAb 425 gamma-1 chain), disulfide with humanized MAb 425 kappa-chain, dimer
- KGaA
- Matuzumab [INN]
- Merck KGaA
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Matuzumab REF: TM-T9922CAS: 339186-68-4 | 98% | Prezzo su richiesta | Lun 06 Mag 24 |
 | Matuzumab - 10 mg/ml REF: 3D-BM165590CAS: 339186-68-4 | Min. 95 Area-% | 1.045,00 €~1.605,00 € | Mar 14 Mag 24 |
Matuzumab
CAS:339186-68-4
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity …
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
N/A
Ref: TM-T9922
| 5mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 06 Maggio 2024
Matuzumab - 10 mg/ml
CAS:339186-68-4
Intereferes with EGFR homodimerisation; cancer therapy
Purezza:
Min. 95 Area-%
Colore e forma:
Powder
Ref: 3D-BM165590
| 1mg | 1.045,00 € | |
| 2mg | 1.285,00 € | |
| 5mg | 1.605,00 € |
Consegna stimata in Stati Uniti, il Martedì 14 Maggio 2024
